FOXO4-DRI: the complete guide.

The short version.

If you read nothing else, read this. The whole guide in a handful of bullets.

Quick reference.

What is FOXO4-DRI?

FOXO4-DRI is a short peptide, which simply means a small chain of amino acids, the same building blocks that make up the proteins in your body. The "DRI" stands for D-retro-inverso, a lab trick that flips and mirrors the molecule so it survives longer in the body and resists being broken down quickly.

It belongs to a class of compounds called senolytics, which target senescent cells. Senescent cells are sometimes called "zombie" cells: they have stopped dividing but refuse to die, and they leak inflammatory signals that researchers link to many features of aging. They build up slowly as we get older.

The version sold by vendors arrives as a freeze-dried white powder in a small sealed vial. It is not a steroid, not a hormone, and not a stimulant. People reach for it because of one striking idea: that clearing these aged cells might roll back some of the wear that comes with age, the way it appeared to in mice.

Worth saying plainly: FOXO4-DRI is not an approved medicine anywhere, and the human evidence is essentially nonexistent. It is sold strictly for research use only, and the exciting results come from aged mice and lab dishes, not people. Because it works by pushing cells toward death, this is not a casual compound. We get into what that means further down.

How it works in the body.

You do not need a biology degree to follow this. Here is the simple picture, then a little more for the curious.

The core idea is clever. Senescent cells avoid dying by hijacking the body's own self-destruct system, and FOXO4-DRI is a decoy that takes that brake off, but only in cells that are relying on it.

• The self-destruct switch (p53). Every cell carries p53, a protein that can order the cell to die when something is wrong. Senescent cells stay alive by keeping p53 tied up and away from the mitochondria, where it would trigger that death signal.
• The FOXO4 leash. They use a protein called FOXO4 to hold p53 in check. FOXO4-DRI is built to slot into that connection as a decoy, breaking the FOXO4 to p53 grip and releasing p53 to do its job.
• Selective clearance. Once freed, p53 moves to the mitochondria and triggers apoptosis, programmed cell death, in the senescent cell. Healthy cells are not leaning on this trick, so the effect is meant to be selective for the aged "zombie" cells.

How to take it: routes of administration.

FOXO4-DRI is an injectable peptide, and unlike some peptides it is not a meaningful oral option. In practice there is only one real route, so the honest comparison is short.

Where to inject.

If you go this route, these are the sites people use. Rotate so no single area gets sore.

The easiest spots are the belly (about 2 inches either side of the navel), the love handles, the front of the thigh, and the back of the upper arms. Rotate every injection.

So which should a beginner pick? Realistically there is only one answer: subcutaneous. The needle is tiny, absorption is reliable, and because FOXO4-DRI works through the whole body, you do not need to inject anywhere clever. The more important decision is not the route, it is whether the thin evidence justifies running it at all.

Reconstitution: mixing it.

FOXO4-DRI arrives as a dry powder, so before you can inject it you reconstitute it, which just means adding liquid to turn the powder into something you can draw into a syringe. It sounds technical but takes about a minute.

Once it is mixed, the only real question is how many units to draw. That depends on your vial size, your water amount, and your target dose, and it is easy to get wrong by hand.

• Use bacteriostatic water, often called BAC water. The small amount of preservative keeps the mixed vial usable for weeks.
• Add the water slowly, down the inside wall of the vial. A common mix is a 10 mg vial plus 2 mL of BAC water, which gives a concentration of 5 mg/mL.
• Swirl, do not shake. Gently roll the vial until the powder dissolves. Shaking can damage the peptide.
• Store it in the fridge once mixed, and keep it out of direct light.

Open the dosage calculator to turn your vial and dose into an exact number of units. As a worked example: a 10 mg vial mixed with 2 mL of BAC water gives 5 mg/mL, so a 1 mg dose is 0.2 mL, which is 20 units on a U-100 insulin syringe, and that vial holds about 10 doses.

Dosing by goal.

There is no validated human dose for FOXO4-DRI, because it has never been through a human trial. What follows is the range people commonly run, extrapolated from animal studies. The defining feature of FOXO4-DRI dosing is that it is pulsed, not continuous.

Pulse course

The most common community pattern is about 1 mg subcutaneously each morning, run 5 days on and 2 days off, for a single 1 to 2 week course. The idea is a short, sharp window to clear senescent cells, then stop.

Between courses

People do not run FOXO4-DRI continuously. After a course they take a long break, often months, and repeat the pulse only a couple of times a year at most. Because the peptide pushes cells toward death, less is generally treated as safer.

The dose-gap problem

Be aware that the original mouse studies used doses scaled to body weight that do not translate cleanly to a flat human milligram dose. The community 1 mg figure is a convention, not a validated number, and reasonable people disagree about it. This uncertainty is a real reason for caution.

Cycling and timing.

A cycle just means a defined run of time on the peptide, followed by a break. For FOXO4-DRI the common pattern is a short pulse of one to two weeks, then a long stretch off, repeated only a couple of times a year, rather than anything ongoing.

Why not run it longer? Because it works by pushing cells toward death and there is no human safety data at all. The cautious and widely followed approach is a brief, infrequent course, which also matches how the senolytic idea is supposed to work: clear the debris, then let the body recover.

• Keep courses short, typically one to two weeks of daily dosing, then stop completely.
• Leave long gaps, months between pulses, repeating only a few times a year at most.
• Do not stack senolytics blindly. If symptoms or concerns come up, that is a conversation for a licensed provider, not a forum.

Stacking FOXO4-DRI.

FOXO4-DRI is usually run on its own, then sequenced with other compounds rather than blended into one shot. The guiding idea is clear the old cells first, then rebuild.

See full recipes, dosing, and how people run them on the stacks page.

Side effects and safety.

In the reports we see, FOXO4-DRI side effects are described as mostly mild when they show up, but the honest headline is that human safety data simply does not exist. The effects people mention most often are:

• Injection-site reactions, a little redness, soreness, or a small bump, which is why rotating sites matters.
• Mild flu-like feeling that some people describe during a course.
• Fatigue or low energy, sometimes reported while dosing.
• Temporary GI discomfort, reported by some users.

Who should be cautious.

Some people have clear reasons to be extra careful, or to avoid FOXO4-DRI entirely until they have spoken with a licensed provider.

• Pregnant or breastfeeding. There is no safety data here, and a compound that triggers cell death is a hard avoid.
• A history of cancer, or active cancer. FOXO4-DRI acts directly on the p53 pathway, which is central to cancer biology. This is a conversation for an oncologist, not a forum, and many would avoid it outright.
• Anyone on other medications. If you take prescription drugs or manage a chronic condition, talk to your provider first, especially given how little is known.
• Anyone wanting proven results. If you need evidence-backed benefits in humans, this peptide cannot offer them yet. That is a fair reason to wait.

And the universal one: whoever you are, talk to a licensed healthcare provider before starting FOXO4-DRI. This guide is educational, not a substitute for personalized medical advice.

Where to buy it safely.

This is where a lot of beginners get burned, because peptide quality varies wildly between vendors and the cheapest vial is not always the real deal. With a compound this potent and this poorly studied, identity and purity matter even more. Our honest take: do not shop on price alone, shop on price plus independent lab data.

• Compare vendors side by side. Price ranges are wide, and the difference between the lowest and highest listing can be large for the exact same compound.
• Look for recent third-party lab tests. The gold standard the community looks for is a recent Janoshik certificate of analysis showing purity for the batch you are actually buying.
• Favor recent COAs. An old lab result on a different batch tells you little. The fresher the test, the more it means.
• Be skeptical of suspiciously cheap listings with no testing behind them, especially for a niche senolytic.

That is exactly the comparison we put together. On our FOXO4-DRI product page you can compare vendor prices, see which batches have public lab data, and view the grades we assign from that data. From there you can head to the buy page to line up your options.

Questions, answered straight.